| [1] |
Baldwin WM 3rd, Valujskikh A, Fairchild RL. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts[J]. Curr Opin Organ Transplant, 2016, 21(1):7-14. DOI: 10.1097/MOT.0000000000000262.
|
| [2] |
Becker LE, Morath C, Suesal C. Immune mechanisms of acute and chronic rejection[J]. Clin Biochem, 2016, 49(4/5):320-323. DOI: 10.1016/j.clinbiochem.2016.02.001.
|
| [3] |
Zhuang Q, Liu Q, Divito SJ, et al. Graft-infiltrating host dendritic cells play a key role in organ transplant rejection[J]. Nat Commun, 2016, 7:12623. DOI: 10.1038/ncomms12623.
|
| [4] |
Gorbacheva V, Fan R, Fairchild RL, et al. Memory CD4 T cells induce antibody-mediated rejection of renal allografts[J]. J Am Soc Nephrol, 2016, 27(11):3299-3307. doi: 10.1681/ASN.2015080848
|
| [5] |
Dean PG, Griffin MD. Bad. emory: CD4 T cell presensitization fosters antibody-mediated kidney transplant rejection[J]. J Am Soc Nephrol, 2016, 27 (11):3231-3233.
|
| [6] |
Legris T, Picard C, Todorova D, et al. Antibody-dependent NK cell activation is associated with late kidney allograft dysfunction and the complement-independent alloreactive potential of donor-specific antibodies[J]. Front Immunol, 2016, 7:288. DOI: 10.3389/fimmu.2016.00288.
|
| [7] |
Kohei N, Tanaka T, Tanabe K, et al. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts[J]. Kidney Int, 2016, 89(6):1293-1306. DOI: 10.1016/j.kint.2016.02.030.
|
| [8] |
Lin CM, Plenter RJ, Coulombe M, et al. Interferon gamma and contact-dependent cytotoxicity are each rate limiting for natural killer cell-mediated antibody-dependent chronic rejection[J]. Am J Transplant, 2016, 16(11):3121-3130. DOI: 10.1111/ajt.13865.
|
| [9] |
Levine MH, Wang Z, Xiao H, et al. Targeting Sirtuin-1 prolongs murine renal allograft survival and function[J]. Kidney Int, 2016, 89(5):1016-1026. DOI: 10.1016/j.kint.2015.12.051.
|
| [10] |
Fairchild RL. Juicing Tregs in situ to improve kidney allograft outcomes[J]. Kidney Int, 2016, 89(5):976-978. DOI: 10.1016/j.kint.2016.01.020.
|
| [11] |
Saha A, O'Connor RS, Thangavelu G, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality[J]. J Clin Invest, 2016, 126(7):2642-2660. DOI: 10.1172/JCI85796.
|
| [12] |
Chesneau M, Michel L, Dugast E, et al. Tolerant kidney transplant patients produce B cells with regulatory properties[J]. J Am Soc Nephrol, 2015, 26(10):2588-2598. DOI: 10.1681/ASN.2014040404.
|
| [13] |
Strober S. Use of hematopoietic cell transplants to achieve tolerance inpatients with solid organ transplants[J]. Blood, 2016, 127(12):1539-1543. DOI: 10.1182/blood-2015-12-685107.
|
| [14] |
Hotta K, Aoyama A, Oura T, et al. Induced regulatory T cells in allograft tolerance via transient mixed chimerism[J]. JCI Insight, 2016, 1(10).
|
| [15] |
Hu M, Wang YM, Wang Y, et al. Regulatory T cells in kidney disease and transplantation[J]. Kidney Int, 2016, 90(3):502-514. DOI: 10.1016/j.kint.2016.03.022.
|
| [16] |
Petrelli A, Tresoldi E, Mfarrej BG, et al. Generation of donor-specific T regulatory type 1 cells from patients on dialysis for cell therapy after kidney transplantation[J]. Transplantation, 2015, 99(8):1582-1589. DOI: 10.1097/TP.0000000000000751.
|
| [17] |
van der Net JB, Bushell A, Wood KJ, et al. Regulatory T cells: first steps of clinical application in solid organ transplantation[J]. Transpl Int, 2016, 29(1):3-11. DOI: 10.1111/tri.12608.
|
| [18] |
Bushell AR, van der Net J, Game DS, et al. The UK ONE Study trial:satety and feasibility of Treg therapy in renal transplantation[J]. Transplantation, 2016, 100(7S):S120. DOI: 10.1111/tri.12608.
|
| [19] |
MacDonald KG, Hoeppli RE, Huang Q, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor[J]. J Clin Invest, 2016, 126(4):1413-1424. DOI: 10.1172/JCI82771.
|
| [20] |
Edinger M. Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation[J]. J Clin Invest, 2016, 126(4):1248-1250. DOI: 10.1172/JCI86827.
|
| [21] |
Bézie S, Picarda E, Ossart J, et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance[J]. J Clin Invest, 2015, 125(10):3952-3964. DOI: 10.1172/JCI81227.
|
| [22] |
Kim JI, Turka LA. Transplant tolerance: a new role for IL-34[J]. J Clin Invest, 2015, 125(10):3751-3753. DOI: 10.1172/JCI84010.
|
| [23] |
Gonzalez-Martin A, Adams BD, Lai M, et al. The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity[J]. Nat Immunol, 2016, 17(4):433-440. DOI: 10.1038/ni.3385.
|
| [24] |
Montero RM, Sacks SH, Smith RA. Complement-here, there and everywhere, but what about the transplanted organ?[J]. Semin Immunol, 2016, 28(3):250-259. DOI: 10.1016/j.smim.2016.04.007.
|
| [25] |
Aufhauser DD Jr, Wang Z, Murken DR, et al. Improved renal ischemia tolerance in females influences kidney transplantation outcomes[J]. J Clin Invest, 2016, 126(5):1968-1977. DOI: 10.1172/JCI84712.
|
| [26] |
Noel S, Desai NM, Hamad AR, et al. Sex and the single transplanted kidney[J]. J Clin Invest, 2016, 126(5):1643-1645. DOI: 10.1172/JCI87428.
|
| [27] |
Wyatt CM, Coates PT, Reeves WB. Of mice and women: do sex-dependent responses to ischemia-reperfusion injury in rodents have implications for delayed graft function in humans?[J]. Kidney Int, 2016, 90(1):10-13. DOI: 10.1016/j.kint.2016.05.008.
|
| [28] |
Hosszu A, Antal Z, Lenart L, et al. σ1-receptor agonism protects against renal ischemia-reperfusion injury[J]. J Am Soc Nephrol, 2016, DOI: 10.1681/ASN.2015070772 [Epub ahead of print].
|
| [29] |
Zhang J, Han C, Dai H, et al. Hypoxia-inducible factor-2α limits natural killer T cell cytotoxicity in renal ischemia/reperfusion injury[J]. J Am Soc Nephrol, 2016, 27(1):92-106. DOI: 10.1681/ASN.2014121248.
|
| [30] |
Amrouche L, Desbuissons G, Rabant M, et al. MicroRNA-146a in human and experimental ischemic AKI: CXCL8-dependent mechanism of action[J]. J Am Soc Nephrol, 2016, DOI:10.1681/ASN.2016010045 [Epub ahead of print].
|
| [31] |
Rogers NM, Zhang ZJ, Wang JJ, et al. CD47 regulates renal tubular epithelial cell self-renewal and proliferation following renal ischemia reperfusion[J]. Kidney Int, 2016, 90(2):334-347. DOI: 10.1016/j.kint.2016.03.034.
|
| [32] |
Karim AS, Reese SR, Wilson NA, et al. Nox2 is a mediator of ischemia reperfusion injury[J]. Am J Transplant, 2015, 15(11): 2888-2899. DOI: 10.1111/ajt.13368.
|
| [33] |
Farrar CA, Zhou W, Sacks SH. Role of the lectin complement pathway in kidney transplantation[J]. Immunobiology, 2016, 221(10):1068-1072. DOI: 10.1016/j.imbio.2016.05.004.
|
| [34] |
Qin L, Li G, Kirkiles-Smith N, et al. Complement C5 inhibition reduces T cell-mediated allograft vasculopathy caused by both alloantibody and ischemia reperfusion injury in humanized mice[J]. Am J Transplant, 2016, DOI: 10.1111/ajt.13834 [Epub ahead of print].
|
| [35] |
Yu ZX, Qi S, Lasaro MA, et al. Targeting complement pathways during cold ischemia and reperfusion prevents delayed graft function[J]. Am J Transplant, 2016, 16(9):2589-2597. DOI: 10.1111/ajt.13797.
|
| [36] |
Castellano G, Intini A, Stasi A, et al. Complement modulation of anti-aging factor Klotho in ischemia/reperfusion injury and delayed graft function[J]. Am J Transplant, 2016, 16(1):325-333. DOI: 10.1111/ajt.13415.
|
| [37] |
Allen MB, Reese PP. Transforming living kidney donation with a comprehensive strategy[J]. PLoS Med, 2016, 13(2):e1001948. DOI: 10.1371/journal.pmed.1001948.
|
| [38] |
Denner J, Tönjes RR. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses[J]. Clin Microbiol Rev, 2012, 25(2):318-343. DOI: 10.1128/CMR.05011-11.
|
| [39] |
Doudna JA, Charpentier E. Genome editing. the new frontier of genome engineering with CRISPR-Cas9[J]. Science, 2014, 346(6213):1258096. DOI: 10.1126/science.1258096.
|
| [40] |
Yang L, Güell M, Niu D, et al. Genome-wide inactivation of porcine endogenous retroviruses (PERVs)[J]. Science, 2015, 350(6264):1101-1104. DOI: 10.1126/science.aad1191.
|
| [41] |
Jarchum I. Getting rid of PERVs[J]. Nat Biotechnol, 2016, 34(1):46. DOI: 10.1038/nbt.3448.
|
| [42] |
Salomon DR. A CRISPR way to block PERVs--engineering organs for transplantation[J]. N Engl J Med, 2016, 374(11):1089-1091. DOI: 10.1056/NEJMcibr1515623.
|
| [43] |
Butler JR, Martens GR, Estrada JL, et al. Silencing porcine genes significantly reduces human-anti-pig cytotoxicity profiles: an alternative to direct complement regulation[J]. Transgenic Res, 2016, 25(5):751-759. DOI: 10.1007/s11248-016-9958-0.
|
| [44] |
Kang JT, Cho B, Ryu J, et al. Biallelic modification of IL2RG leads to severe combined immunodeficiency in pigs[J]. Reprod Biol Endocrinol, 2016, 14(1):74. DOI: 10.1186/s12958-016-0206-5.
|
| [45] |
Butler JR, Martens GR, Li P, et al. The fate of human platelets exposed to porcine renal endothelium: a single-pass model of platelet uptake in domestic and genetically modified porcine organs[J]. J Surg Res, 2016, 200(2):698-706. DOI: 10.1016/j.jss.2015.08.034.
|
| [46] |
Baan CC. Basic sciences in development: What changes will we see in transplantation in the next five years?[J]. Transplantation, 2016, DOI: 10.1097/TP.0000000000001518 [Epub ahead of print].
|
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: